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Angiographic Correlates in
Type 1 and 2 MI by the
Universal Deﬁnition
In the 1980s, the angiographic morphology of culprit lesions
in unstable angina and acute myocardial infarction (AMI) was
described distinct from that seen in stable angina (1,2). These
lesions were originally designated as “type 2 eccentric” and
later on as “complex lesions.” They were found in 70% of
patients with an acute coronary syndrome and 20% in stable
angina patients. These lesions were thought to represent
plaque rupture and/or thrombus formation (3).
Over the years, both the terminology and diagnostic criteria
of acute coronary syndrome have evolved. Recently, a new
universal definition of myocardial infarction was proposed
based on the pathophysiology of AMI, which was defined as
an increase and decrease in troponin in the presence of clinical
evidence of ischemia (4). Of the types of AMI defined in this
communication, type 1 myocardial infarction (MI) included
patients with evidence of plaque rupture or erosion in an
epicardial coronary vessel, whereas type 2 MI was AMI
precipitated by a primary imbalance in the myocardial blood
supply to myocardial oxygen demand ratio. Although morpho-
logical and angiographic findings in AMI have been previously
reported, the angiographic findings in these 2 distinct subsets
of AMI have not. We hypothesized that in type 1 MI, the
angiographic findings should mirror previous studies (1,2)
with a predominance of complex lesions in both ST-segment
elevation myocardial infarction (STEMI) and non–ST-
segment elevation myocardial infarction (NSTEMI), whereas
in type 2 MI, culprit vessels and complex lesions would be
infrequent.
The population was part of a prospective evaluation of
patients presenting to a large community hospital with ele-
vated troponin I levels. The clinical findings were previously
published in part by Javed et al. (5). Type 1 MI required
clinical ischemia and a presumed primary coronary event such
as plaque rupture/erosion based on presentation, without a
secondary clinical condition associated with a supply/demand
mismatch such as a tachyarrhythmia, severe hypertension, and
hypotension. Type 2 MI required a primary documented
disturbance in supply/demand. In 10 of 31 cases, an angiogram
was necessary to confirm a type 2 MI. These patients pre-
sented with typical ischemic chest pain either secondary to
uncontrolled hypertension or presumed coronary spasm from
illicit drug use and had normal or nonobstructive coronary
artery disease on angiography.
The present analysis included all patients with an in-
hospital angiogram and a diagnosis of either type 1 or 2 MI.
Two angiographers, blinded to clinical history, reviewed allngiograms for the following: 1) number of diseased vessels; 2)
he presence of an identifiable culprit lesion and vessel; and 3)
ulprit lesion morphology (complex vs. simple: simple if no
omplex features were identified). A culprit lesion was consid-
red as the only significant lesion on angiography (usually
70% diameter stenosis). In multivessel disease, the culprit
as a significant lesion in a vessel that corresponded to the new
lectrocardiographic changes or wall motion abnormalities. If
ot localizable to a single site, no culprit was assigned in
ultivessel disease. Patients with nonobstructive disease
50% diameter stenosis) or vessels without luminal narrow-
ng were also designated as an MI without a culprit lesion/
essel. The coronary morphology of the culprit lesion was
ualitatively analyzed in orthogonal views. A complex lesion
as defined as an acute or recent total occlusion (dye stasis at
he site) or a patent vessel with a significant lesion that was
sually eccentric with either overhanging edges, abrupt shoul-
ers, ulcerations, and/or filling defects at or distal to the lesion
ndicating intracoronary thrombus.
A total of 224 patients were identified: 193 with type 1 and
1 with type 2 MI. Baseline demographic data are contained
n Table 1. There were no significant differences other than a
igher incidence of chronic kidney disease in the type 2 group
nd higher troponin levels in type 1. In type 1 MI patients, 73
37.8%) had STEMI, whereas 120 (62.2%) had a diagnosis of
STEMI (Fig. 1).
Nearly all type 1 STEMI patients (95%) had an identifiable
ulprit lesion. Nonobstructive/normal or 3-vessel disease was
nfrequent (1.4%). In type 1 NSTEMI patients, an identifiable
Table 1. Baseline Characteristics
Type 1
(n  193)
Type 2
(n  31) p Value
Age, yrs 63 13 67 13 0.13
Men 129 (66.8) 18 (58.1) 0.31
Peak TnI, ng/ml 5.57 (0.05–822.6) 1.00 (0.05–35.18) 0.001
STEMI 44.38 (0.23–822.6)
NSTEMI 1.44 (0.05–337.65)
Diabetes mellitus 82 (42.9) 18 (58.1) 0.14
Dyslipidemia 137 (71.0) 21 (67.7) 0.53
Hypertension 151 (78.2) 27 (87.1) 0.4
Smoker 91 (47.2) 11 (35.5) 0.17
Illicit drug use 20 (10.4) 5 (16.1) 0.42
Chronic kidney disease 32 (16.6) 11 (35.5) 0.02
Obese (BMI 30 kg/m2) 58 (30.1) 5 (16.1) 0.09
Family history of
premature CHD
40 (20.7) 3 (9.7) 0.13
Previous coronary
disease
59 (30.6) 14 (45.2) 0.14
Cardiomyopathy 17 (8.8) 6 (19.4) 0.09
Values are mean  SD, n (%), or median (range).
BMI body mass index; CHD coronary heart disease; NSTEMI non–ST-segment
elevation myocardial infarction; STEMI ST-segment elevation myocardial infarction;
TnI  cardiac troponin I.
myocardial infarction; STEMI  ST-segment elevation myocardial infarction.
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464culprit lesion was found in 56%, and the majority (73%) were
complex. Nonobstructive/normal or 3-vessel disease was present in
10% and 27%, respectively. A culprit lesion could be identified in
43% patients with 3-vessel disease.
Of the 31 type 2 MI patients, only 1 had an identifiable culprit
vessel, and nonobstructive/normal or 3-vessel disease was found in
36% and 32%, respectively. In summary, these data suggest that
culprit lesion morphology and other easily identifiable angiographic
parameters contribute to our understanding of AMI pathogenesis
by the universal definition. These findings support the differentia-
tion of type 1 from type 2 MI.
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Figure 1. Results
(A) The percentage of an identiﬁable culprit lesion for type 1 STEMI, type 1
NSTEMI, and type 2 MI. (B) The percentage of complex lesion morphology
in Type 1 STEMI and NSTEMI with an identiﬁable culprit lesion. (C) The per-
centage of patients with normal/nonobstructive and 3-vessel disease among
type 1 STEMI, type 1 NSTEMI, and type 2 MI. (No statistical analysis was per-
formed for normal/nonobstructive category as angiography was required for
type 2 diagnosis in 10 of 31 with normal/nonobstructive coronary artery
disease.) MI  myocardial infarction; NSTEMI  non–ST-segment elevation
